Theravance Biopharma Inc (TBPH)

Long-Term Debt

$27.77M

Quarterly · Period ending: · USD

TBPH logo

TBPH Long-Term Debt

Latest reported$27.77M
TBPH Quarterly Long-Term Debt ($0.00 → $27.77M)
High-resolution chart · PNG

TBPH long-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Theravance Biopharma Inc Long-Term Debt — Quarterly (USD)
Period endingLong-Term Debt (USD)
27,774,000
62,547,000
64,553,000
33,681,000
35,561,000
37,349,000
39,108,000
40,785,000
42,441,000
43,840,000
45,236,000
41,118,000
42,521,000
43,763,000
45,407,000
51,381,000
675,338,000
659,879,000
652,075,000
657,690,000
660,336,000
659,437,000
647,056,000
659,000,000
649,324,000
647,211,000
492,915,000
496,250,000
491,634,000
494,981,000
454,353,000
224,550,000
224,282,000
224,014,000
223,746,000
223,478,000
223,210,000
222,942,000
222,676,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.